Abstract:Key PointsSmall interfering RNAs (siRNAs) are widely used to study gene function and there is general excitement about their potential for therapeutic applications. However, several hurdles, including a lack of specificity, will have to be overcome before it is possible to use siRNAs therapeutically.siRNAs have multiple types of off-target effects, but there are several methods to help mitigate them.microRNA-like off-target effects refer to siRNA-induced sequence-dependent regulation of unintended transcripts, through partial sequence complementarity to their 3′ UTRs, to produce false-positive phenotypes. Such off-target effects follow the same dose response as on-target effects and therefore cannot be selectively eliminated by reducing siRNA concentration. Off-target siRNA effects are also species-specific.microRNA-like off-target effects can be mitigated by siRNA redundancy, siRNA pooling or chemical modification such as 2′-O-methyl modification.A significant obstacle to the therapeutic application of RNAi is the ability of siRNAs and/or their delivery vehicles (such as cationic lipids) to stimulate the innate immune system and trigger an inflammatory response through activation of Toll-like receptors. Immunostimulatory siRNAs can also produce unwanted toxicities, including elevated levels of serum alanine and aspartate aminotransaminases, and reduced numbers of lymphocytes and platelets.Immunostimulation by siRNAs can be reduced by sequence selection or chemical modification such as substitution of the 2′ position of ribose with 2′-O-methyl, 2′-fluoro, 2′-deoxy or locked nucleic acid.A novel non-specific effect of RNAi expression relates to saturation of the RNAi machinery; exogenous siRNAs can saturate the endogenous RNAi machinery causing widespread effects on microRNA processing and function.Understanding the sources of siRNA off-target activity is yielding insights into siRNA design and chemical modification. Much progress has been made in the design of effective siRNAs with reduced off-target liabilities and continued research in this area will undoubtedly lead to further improvements in the development of siRNAs for therapeutic applications.

[The Application of Sirna in Therapeutics].

Using RNAi to Identify Drug Targets and Using Sirnas to Cure Diseases

The development of RNA interference in the study and application of clinical treatment

Research Progress on Sirna Delivery with Nonviral Carriers

Application of RNA Interference in the Treatment of Diseases

Research progress of the methods and atrategies of introducing small interference RNA into mammals

RNA Interference and Potential Applications

Pharmacokinetic Perspective and the Delivery of Sirna in Vivo

Rna Interference: A Potent Tool for Gene-Specific Therapeutics

Nanoparticle Delivery Systems for Sirna-Based Therapeutics

The Application of the RNA Interference Technology in the Gene Therapy

Advances in Research and Applications of Gene-Silencing Technologies Induced by Sirnas

Development and applications of RNAi technology in drug research

Therapeutic Potentials of Gene Silencing by RNA Interference: Principles, Challenges, and New Strategies.

Advances on Research of RNA Interference

Current progress of siRNA/shRNA therapeutics in clinical trials

Progress on Applications of RNA Interference

Delivery Systems for Sirna Drug Development in Cancer Therapy

Research Advances of siRNA-Based Molecular Medicines

RNA Interference and Its Application to Metabolic Engineering in Medicinal Plants

Recognizing and avoiding siRNA off-target effects for target identification and therapeutic application